Enhancement of the inotropic action of glucagon by small concentration of angiotensin.
D000804:Angiotensin II / Q000008:administration & dosage* / Q000494:pharmacology; D000818:Animals; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005934:Glucagon / Q000008:administration & dosage / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000494:pharmacology; D010210:Papillary Muscles / Q000187:drug effects; D013268:Stimulation, Chemical
D000804:Angiotensin II; D005934:Glucagon; D007545:Isoproterenol; D004837:Epinephrine